rss
08-27-2019, 10:26 PM
Barostim Neo Neuromodulation Device for Heart Failure Wins FDA Approval
https://www.medgadget.com/wp-content/uploads/2019/08/barostim-neo-device.jpg
CVRx, a Minneapolis, Minnesota company, won FDA approval for the first neuromodulation device designed to address heart failure. Intended as a treatment option for patients with an ejection fraction
https://www.medgadget.com/wp-content/uploads/2019/08/barostim-neo-device.jpg
CVRx, a Minneapolis, Minnesota company, won FDA approval for the first neuromodulation device designed to address heart failure. Intended as a treatment option for patients with an ejection fraction